BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 36937870)

  • 1. Identification of anoikis-related molecular patterns to define tumor microenvironment and predict immunotherapy response and prognosis in soft-tissue sarcoma.
    Qi L; Chen F; Wang L; Yang Z; Zhang W; Li ZH
    Front Pharmacol; 2023; 14():1136184. PubMed ID: 36937870
    [No Abstract]   [Full Text] [Related]  

  • 2. Cross-Talk of Multiple Types of RNA Modification Regulators Uncovers the Tumor Microenvironment and Immune Infiltrates in Soft Tissue Sarcoma.
    Qi L; Zhang W; Ren X; Xu R; Yang Z; Chen R; Tu C; Li Z
    Front Immunol; 2022; 13():921223. PubMed ID: 35860263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of the molecular subtypes and signatures to predict the prognosis, biological functions, and therapeutic response based on the anoikis-related genes in colorectal cancer.
    Zhai X; Chen B; Hu H; Deng Y; Chen Y; Hong Y; Ren X; Jiang C
    Cancer Med; 2024 May; 13(10):e7315. PubMed ID: 38785271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of anoikis-based molecular heterogeneity in pancreatic cancer and pancreatic neuroendocrine tumor and its association with tumor immune microenvironment and metabolic remodeling.
    Li N; Jia X; Wang Z; Wang K; Qu Z; Chi D; Sun Z; Jiang J; Cui Y; Wang C
    Front Endocrinol (Lausanne); 2023; 14():1153909. PubMed ID: 37234801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel stratification framework based on anoikis-related genes for predicting the prognosis in patients with osteosarcoma.
    Zhang X; Wen Z; Wang Q; Ren L; Zhao S
    Front Immunol; 2023; 14():1199869. PubMed ID: 37575253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integration analysis of senescence-related genes to predict prognosis and immunotherapy response in soft-tissue sarcoma: evidence based on machine learning and experiments.
    Qi L; Chen F; Wang L; Yang Z; Zhang W; Li Z
    Front Pharmacol; 2023; 14():1229233. PubMed ID: 37497116
    [No Abstract]   [Full Text] [Related]  

  • 7. Deciphering the role of NETosis-related signatures in the prognosis and immunotherapy of soft-tissue sarcoma using machine learning.
    Qi L; Chen F; Wang L; Yang Z; Zhang W; Li Z
    Front Pharmacol; 2023; 14():1217488. PubMed ID: 37408763
    [No Abstract]   [Full Text] [Related]  

  • 8. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.
    Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X
    Front Immunol; 2022; 13():1056932. PubMed ID: 36479114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel anoikis-related prognostic signature associated with prognosis and immune infiltration landscape in clear cell renal cell carcinoma.
    Chen Z; Liu X; Zhu Z; Chen J; Wang C; Chen X; Zhu S; Zhang A
    Front Genet; 2022; 13():1039465. PubMed ID: 36338978
    [No Abstract]   [Full Text] [Related]  

  • 10. Identification of anoikis-related subtypes and development of risk stratification system in skin cutaneous melanoma.
    Tian J; Cao ZJ; Zhang Y; Zhou JK; Yang L
    Heliyon; 2023 May; 9(5):e16153. PubMed ID: 37215879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of anoikis-related genes classification patterns and immune infiltration characterization in ischemic stroke based on machine learning.
    Qin X; Yi S; Rong J; Lu H; Ji B; Zhang W; Ding R; Wu L; Chen Z
    Front Aging Neurosci; 2023; 15():1142163. PubMed ID: 37032832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and validation of a novel anoikis-related signature for predicting prognosis and immune landscape in ovarian serous cystadenocarcinoma.
    Zhu YT; Wu SY; Yang S; Ying J; Tian L; Xu HL; Zhang HP; Yao H; Zhang WY; Jin QQ; Yang YT; Jiang XY; Zhang N; Yao S; Zhou SG; Chen G
    Heliyon; 2023 Aug; 9(8):e18708. PubMed ID: 37554782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An anoikis-based gene signature for predicting prognosis in malignant pleural mesothelioma and revealing immune infiltration.
    Shi J; Peng B; Zhou X; Wang C; Xu R; Lu T; Chang X; Shen Z; Wang K; Xu C; Zhang L
    J Cancer Res Clin Oncol; 2023 Oct; 149(13):12089-12102. PubMed ID: 37421452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction of a novel anoikis-related prognostic model and analysis of its correlation with infiltration of immune cells in neuroblastoma.
    Chen J; Sun M; Chen C; Kang M; Qian B; Sun J; Ma X; Zhou J; Huang L; Jiang B; Fang Y
    Front Immunol; 2023; 14():1135617. PubMed ID: 37081871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Tumor Antigens and Immune Subtypes for the Development of mRNA Vaccines and Individualized Immunotherapy in Soft Tissue Sarcoma.
    Wu C; Duan Y; Gong S; Osterhoff G; Kallendrusch S; Schopow N
    Cancers (Basel); 2022 Jan; 14(2):. PubMed ID: 35053609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a novel anoikis-related gene signature to predict prognosis and tumor microenvironment in lung adenocarcinoma.
    Diao X; Guo C; Li S
    Thorac Cancer; 2023 Jan; 14(3):320-330. PubMed ID: 36507553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of anoikis-related gene PLK1 in kidney renal papillary cell carcinoma: a bioinformatics analysis and preliminary verification on promoting proliferation and migration.
    Gan L; Xiao Q; Zhou Y; Fu Y; Tang M
    Front Pharmacol; 2023; 14():1211675. PubMed ID: 37456749
    [No Abstract]   [Full Text] [Related]  

  • 18. Comprehensive analysis of anoikis-related long non-coding RNA immune infiltration in patients with bladder cancer and immunotherapy.
    Zhang YY; Li XW; Li XD; Zhou TT; Chen C; Liu JW; Wang L; Jiang X; Wang L; Liu M; Zhao YG; Li SD
    Front Immunol; 2022; 13():1055304. PubMed ID: 36505486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel anoikis-related risk model predicts prognosis in patients with colorectal cancer and responses to different immunotherapy strategies.
    Yang L; Xu F
    J Cancer Res Clin Oncol; 2023 Sep; 149(12):10879-10892. PubMed ID: 37318595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Construction of a novel molecular typing and scoring system for anoikis distinguishes between different prognostic risks and treatment responsiveness in low-grade glioma.
    Zhang G; Chen A; Fang J; Wu A; Chen G; Tai P; Chen H; Chen X; Cao K
    Front Immunol; 2023; 14():1105210. PubMed ID: 37114037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.